CDK9 and cancer: Consultation of cancer genome repositories such as cBioPortal [247,248], the COSMIC database [254] and TumorPortal [255] reveals a variety of other missense mutations within CDK–cyclins in the context of cancer (e.g. R168C in CDK5, R86Q CDK9, R378G in cyclin A2).